New model aims to speed up rare disease diagnosis
NCT ID NCT07558213
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new way to care for people with rare diseases. It will use advanced genetic testing and a team of specialists to help diagnose patients faster and coordinate their care better. The study involves 136 participants with certain rare diseases and aims to reduce the time to diagnosis and improve follow-up.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to faster diagnoses and better coordinated care for people with rare diseases.
- What could go wrong
- This is an observational study focused on improving processes, not testing a new treatment. It is small and may not apply to all rare diseases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSMORPHIC DISORDER, BODY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Policlinico Universitario A. Gemelli Irccs
Roma, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-shot gene editor aims to correct a brain disorder at its source
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Worldwide data pool could pave the way for mitochondrial disease trials
- Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
- Biobank aims to unlock genetic secrets of rare diseases
- AI could shorten the long road to a rare disease diagnosis